AstraZeneca SWOT Analysis, Competitors & USP

Posted in Pharma and Healthcare, Total Reads: 11968

SWOT analysis of AstraZeneca analyses the brand/company with its strengths, weaknesses, opportunities & threats. In AstraZeneca SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like AstraZeneca to benchmark its business & performance as compared to the competitors and industry. AstraZeneca is one of the leading brands in the pharma and healthcare sector. The table below also lists the top AstraZeneca competitors and elaborates AstraZeneca market segmentation, target group, positioning & Unique Selling Proposition (USP).

AstraZeneca SWOT, Competitors, Marketing STP & Brand analysis Table
AstraZeneca Brand Analysis
Parent Company

AstraZeneca Biopharmaceuticals

Category

Pharmaceutical

Sector

Pharma and Healthcare

Tagline/ Slogan

Health connects us all

USP

AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.

AstraZeneca STP
Segment

Cardiovascular, neuroscience, gastrointestinal, oncology, infection & respiratory diseases

Target Group

Healthcare professionals, doctors, hospitals offering treatments for above mentioned diseases

Positioning

They are responsible for development of prescription medicines for six important areas of healthcare such as cancer, infection.

AstraZeneca SWOT Analysis
Strengths

Below is the Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis of AstraZeneca. Strengths are:

1. Rapid decision making & streamlined due diligence processing

2. Good commercial and R&D presence in emerging markets

3. Active in over 100 countries employing over 60,000 people

4. High investment in R&D with 11,000+ dedicated R&D team

5. Ten products with global sales above 1 billion dollar
6. Product portfolio includes cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation medicines


Weakness

Here are the weaknesses in the AstraZeneca SWOT Analysis:

1. It was affected by drug shortage crisis as in case of Cefotan

2. Product discontinuation affects the performance

3. Legal proceedings related to patents and pricing issues affect image

Opportunities

Following are the Opportunities in AstraZeneca SWOT Analysis:

1. It can leverage its strong presence in emerging markets

2. Increasing importance of biosimiler market

3. Increasing global ageing population

Threats

The threats in the SWOT Analysis of AstraZeneca are as mentioned:

1. Seroquel  their blockbuster drug is facing threat of copycat generic drugs

2. Stringent drug development guidelines
3. Competition coming up with effective drugs

AstraZeneca Competition
Competitors

Below are the top 4 AstraZeneca competitors:

1. Amgen
2. Genentech

3. Teva Pharmaceuticals

4. GlaxoSmithKline

The brandguide table above concludes the AstraZeneca SWOT analysis along with its marketing and brand parameters.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to AstraZeneca. The BrandGuide section covers SWOT Analysis, USP, STP & Competition of more than 6000 brands from over 20 categories. This SWOT and marketing analysis has been researched & authored by our BrandGuide Research Team members.

Search & Explore : BrandGuide


The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only. Utmost care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.

Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin